Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000521177 | SCV000621106 | likely pathogenic | not provided | 2018-07-17 | criteria provided, single submitter | clinical testing | This variant is denoted SDHD c.315-1G>A or IVS3-1G>A and consists of a G>A nucleotide substitutionat the -1 position of intron 3 of the SDHD gene. This variant destroys a canonical splice acceptor site and is predictedto cause abnormal gene splicing, leading to either an abnormal message that is subject to nonsense-mediated mRNAdecay or to an abnormal protein product. This variant has not, to our knowledge, been published in the literature.Based on the currently available information, we consider SDHD c.315-1G>A to be a likely pathogenic variant. Of note,variants in the SDHD gene exhibit a parent-of-origin effect and, if shown to be pathogenic, typically cause symptomsonly if inherited from the father. |
Fulgent Genetics, |
RCV002481730 | SCV002802606 | likely pathogenic | Carney-Stratakis syndrome; Pheochromocytoma; Paragangliomas 1; Mitochondrial complex 2 deficiency, nuclear type 3 | 2021-12-17 | criteria provided, single submitter | clinical testing |